Xeris Pharmaceuticals Inc. (XERS) Tops Q4 EPS by 4c, provides guidance

Go back to Xeris Pharmaceuticals Inc. (XERS) Tops Q4 EPS by 4c, provides guidance
(NASDAQ: XERS) Delayed: 8.55 +0.22 (2.64%)
Previous Close $8.33    52 Week High
Open $8.33    52 Week Low
Day High $8.67    P/E N/A 
Day Low $8.25    EPS
Volume 1,047,129